General Information
Version
6.3
Revision date
2024-12-19
Product name
Ditalimfos
CAS No.
5131-24-8
REACH No
A
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H311, H315, H317
Hazard statements
Code
Statements
H311
Toxic in contact with skin
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H311 Toxic in contact with skin. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H311 Toxic in contact with skin. H317 May cause an allergic skin reaction.
Precautionary statements
P261 Avoid breathing dust. P264 Wash skin thoroughly after handling. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves/ protective clothing. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P261 Avoid breathing dust. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves/ protective clothing. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 as amended by GB-CLP Regulation, UK SI 2019/720, and UK SI 2020/1567 Acute toxicity, (Category 3) H311: Toxic in contact with skin. Skin irritation, (Category 2) H315: Causes skin irritation. Skin sensitization, (Category 1) H317: May cause an allergic skin reaction.
